FANDOM



Curing the Common Clone (Sector 1)(1)
StartBearer Amani
EndBearer Amani
FactionLightbearers
Mission ItemsBlood Sample Kit
ChainCuring the Common Clone (Sector 1)(1)
Curing the Common Clone (Sector 1)(2)
Curing the Common Clone (Sector 1)(3)
Time LimitUnlimited
SectorPlateau
AreaWatchtower
Curing the Common Clone (Sector 1)(1)
StartBearer Jaida
EndBearer Jaida
FactionLightbearers
Mission ItemsBlood Sample Kit
ChainCuring the Common Clone (Sector 1)(1)
Curing the Common Clone (Sector 1)(2)
Curing the Common Clone (Sector 1)(3)
Time LimitUnlimited
SectorPlateau
AreaEmbry Crossroads
Curing the Common Clone (Sector 1)(1)
StartBearer Dimario
EndBearer Dimario
FactionLightbearers
Mission ItemsBlood Sample Kit
ChainCuring the Common Clone (Sector 1)(1)
Curing the Common Clone (Sector 1)(2)
Curing the Common Clone (Sector 1)(3)
Time LimitUnlimited
SectorPlateau
AreaOdenville
 


Have you come to help? We're in trouble -- the whole Province, but especially clones. The Vistas and CHOTA are working with us to try and get things under control.


Something's gone wrong with the LifeNet pods. They're spilling out these things, these Infected. The Infected aren't very tough, but most of them carry nanites that can get into you and impair your nervous system. I'm not yet sure if the medicine I've got will work.


Can you take this injector and get a sample of infected blood so I can get a better look? If we can make a cure it'll go a long way towards clearing out this menace.
MissionVTell me more.
MissionXNo thanks.


Curing the Common Clone (Sector 1)
Goal:
Mission-Use Blood Sample Kit on infected

Mission:
The Lighthearers, Vistas, and CHOTA of the Plateau want you to obtain a sample of Infected blood to help them make a cure. You may obtain the sample from any Infected in the sector.

MissionAccept



Completion

Let me see. Hmm. Okay, yes! I can cure this!

 

Notes

  • This mission has no faction requirements. Any player can take it.
  • This mission was available only during the Halloween Event in 2018.
Community content is available under CC-BY-SA unless otherwise noted.